Health
Revolutionary Pancreatic Cancer Drug Approved by FDA
By Editor • August 26, 2026 • 1 min read
The FDA has approved daraxonrasib, a pioneering pill for pancreatic cancer that blocks a protein responsible for tumor growth in over 90% of cases.
Read more